Lexicon Voluntarily Withdraws Sotagliflozin New Drug Application and Plans Prompt Resubmission Targeted Early Q2 2022GlobeNewsWire • 02/28/22
Lexicon Pharma Pulls Sotagliflozin US Application Due To Technical Issue, Shares FallBenzinga • 02/28/22
Lexicon Pharmaceuticals to Host Fourth Quarter 2021 Financial Results Conference Call and Webcast on February 28, 2022GlobeNewsWire • 02/26/22
Lexicon Pharmaceuticals Outlines Major Potential Value Drivers for 2022 at 40th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/13/22
Lexicon Pharmaceuticals to Participate in The 40th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/04/22
Lexicon Submits New Drug Application for Sotagliflozin for the Treatment of Heart Failure in Adults With Type 2 DiabetesGlobeNewsWire • 12/30/21
Lexicon Pharmaceuticals to Participate in the Jefferies London Healthcare Conference and the Piper Sandler 33rd Annual Healthcare ConferenceGlobeNewsWire • 11/15/21
Lexicon's Sotagliflozin Demonstrates Benefits in Heart Failure and Blood Glucose Control Across the Full Range of Kidney Function in New Analysis of Clinical DataGlobeNewsWire • 11/14/21
Lexicon Pharmaceuticals, Inc. (LXRX) CEO Lonnel Coats on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/04/21
Lexicon Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Clinical UpdateGlobeNewsWire • 11/03/21
Lexicon Pharmaceuticals to Host Third Quarter 2021 Financial Results Conference Call and Webcast on November 3, 2021GlobeNewsWire • 10/28/21
Lexicon Welcomes New ESC Heart Failure Treatment Guidelines Establishing SGLT Inhibitors as Standard of CareGlobeNewsWire • 08/30/21
Lexicon's Sotagliflozin Demonstrates Additional Compelling Benefits in Reducing Cardiovascular Endpoints: Results from Soloist and Scored TrialsGlobeNewsWire • 08/23/21
Craig Granowitz, M.D., Ph.D. Joins Lexicon as Senior Vice President and Chief Medical OfficerGlobeNewsWire • 07/30/21
Lexicon Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical UpdateGlobeNewsWire • 07/30/21
Lexicon Pharmaceuticals to Host Second Quarter 2021 Financial Results Conference Call and Webcast on July 30, 2021GlobeNewsWire • 07/28/21
Will Lexicon Pharmaceuticals (LXRX) Report Negative Q2 Earnings? What You Should KnowZacks Investment Research • 07/22/21